Guidance for industry : Q3B(R2) impurities in new drug products.

Bibliographic Details
Corporate Authors:	Center for Drug Evaluation and Research (U.S.) Center for Biologics Evaluation and Research (U.S.) International Conference on Harmonisation
Language:	English
Published:	Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, [2006]
Subjects:	Drug development > Government policy > United States. Drug adulteration > Government policy > United States.
Online Access:	Connect to online resource - All users (Federal Depository Library Program Persistant URL)
Physical Description:	8 pages : digital, PDF file
Variant Title:	Q3B(R2) impurities in new drug products Impurities in new drug products
Format:	Government Document Electronic Conference Proceeding eBook

Description
Note:	Title from PDF title page (viewed on June 15, 2009). "ICH". "July 2006" . "Revision 2". Electronic resource.
Call Number:	HE 20.4702:IM 7/2
System Details:	Mode of access: Internet at the FDA web site. Address as of 6/15/09: http://www.fda.gov/downloads/RegulatoryInformation/Guidances/ucm128033.pdf ; current access is available via PURL.